BridgeMD
New treatment option for Spinal Cord Injuries
Official title Prophylactic Pregabalin Treatment Following Spinal Cord Injury
ClinicalTrials.gov ID: NCT06066918
What this study is testing
What is Pregabalin 75mg?
Pregabalin 75mg is an investigational medicine, given as a twice-daily, being studied as a potential treatment for spinal cord injuries.
Also referred to as Lyrica.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Patients arriving to rehabilitation up to 3 months following SCI will be given (study group) or not (control group) Lyrica (75X2). They will be followed for central pain development.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Up to 3 months following traumatic or non-traumatic SCL
- Ability to give informed consent and cooperate
You likely can't join if
- Pregnancy
- Neurological or other medical conditions that may interfere with sensation
- Neuropathic-like pain before recruitment (described as painful sensation of electric current, burning, numbness, tingling, pricking, or squeezing)
- Being treated with Pregabalin
- Blood creatinine levels \>1.2 or creatinine clearance \<60
- Sensitivity to lactose
The study team makes the final eligibility decision.
Where it's taking place
- Raanana, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Raanana, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.